申请人:Buschmann Helmut Heinrich
公开号:US20100074955A1
公开(公告)日:2010-03-25
The present invention relates to an active substance combination comprising at least one compound with 5-HT
6
receptor affinity, and at least NMDA-receptor ligand, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.